BZ Compnat Limited Pharmaceutical Import Profile — Thailand (DGFT 2022–2026)

Name: BZ Compnat Limited Pharmaceutical Import Records from India — 2 Products, $10.7K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

BZ Compnat Limited — Pharmaceutical Importer Profile (2026) | 2 Products, $10.7K Trade | TransData Nexus

BZ Compnat Limited

Pharmaceutical Importer · Thailand · Advanced Oncology Focus · $10.7K Total Trade · DGFT Verified

BZ Compnat Limited is a pharmaceutical importer based in Thailand with a total trade value of $10.7K across 2 products in 2 therapeutic categories. Based on 11 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. BZ Compnat Limited sources from 1 verified Indian supplier, with Viotonic Medication accounting for 100.0% of imports.

BZ Compnat Limited — Import Portfolio & Supplier Network

BZ Compnat Limited import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to BZ Compnat Limited?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Viotonic Medication	$78.0K	99	100.0%

BZ Compnat Limited sources from 1 verified Indian supplier across 33 distinct formulations. The sourcing is highly concentrated — Viotonic Medication accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does BZ Compnat Limited Import?

Formulation	Value	Ships
Mabtas rituximab 500 MG	$8.9K	13
Lenvatol lenvatinitib 4MG	$7.9K	5
Albutein 20% human serum	$6.6K	2
Regonat regorafenib 40MG	$5.8K	2
Gardasil v9 human papiloma	$5.2K	2
Victoza liraglutide	$4.9K	9
Acivir iv acyclovir injection 250 MG	$4.3K	6
Exemptia 40 adalimumab 40MG	$4.0K	2
Nitib ibrutinib 140 MG	$2.9K	3
Lenvat 4MG lenvatinib 4MG	$2.7K	2
Plasmahep human hepatitis b	$2.2K	1
Plasmahep	$2.1K	1
Mirafilter mirafilter	$1.8K	1
Mirafilter mirafilter	$1.8K	1
Nabpac nab paclitaxel 100 MG	$1.8K	2

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Regorafenib	Advanced Oncology	$5.8K	2	0.6%	5
2	Liraglutide	Diabetes & Endocrine	$4.9K	9	0.1%	10

BZ Compnat Limited imports 2 pharmaceutical products across 2 categories into Thailand totaling $10.7K.

BZ Compnat Limited — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

BZ Compnat Limited is a pharmaceutical importer based in Thailand, specializing in the acquisition of finished pharmaceutical formulations. The company operates as a buyer, sourcing a range of pharmaceutical products from international suppliers to meet the domestic market's needs. While specific details about its headquarters and parent company are not publicly disclosed, BZ Compnat Limited plays a significant role in Thailand's pharmaceutical distribution network. Its operations contribute to the availability of essential medications across the country, particularly in the therapeutic areas of oncology and diabetes.

2Distribution Network

Information regarding BZ Compnat Limited's warehouse locations and logistics capabilities is not publicly available. However, as a pharmaceutical importer, the company is likely to have established distribution channels within Thailand to ensure efficient delivery of imported products to various stakeholders, including hospitals, clinics, and pharmacies. The extent of its geographic coverage beyond Thailand is not specified, but the company's focus appears to be primarily on the domestic market.

3Industry Role

In Thailand's pharmaceutical supply chain, BZ Compnat Limited functions as a pharmaceutical importer, sourcing finished pharmaceutical formulations from international suppliers. The company's role is crucial in bridging the gap between foreign manufacturers and the Thai market, ensuring the availability of a diverse range of medications. By importing products, BZ Compnat Limited supports the healthcare system's needs, particularly in specialized therapeutic areas such as oncology and diabetes.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — BZ Compnat Limited

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

BZ Compnat Limited's sourcing strategy exhibits a high degree of concentration, with all 11 shipments valued at $11,000 USD sourced from a single supplier, VIOTONIC MEDICATION. This single-source dependency indicates a strategic choice to maintain a focused and potentially more manageable supplier relationship. However, such concentration also poses risks, including vulnerability to supply disruptions or changes in supplier terms. The consistent volume and value of shipments suggest a stable and ongoing relationship between BZ Compnat Limited and VIOTONIC MEDICATION, which may mitigate some of these risks.

2Supply Chain Resilience

The resilience of BZ Compnat Limited's supply chain appears to be closely tied to its exclusive relationship with VIOTONIC MEDICATION. The lack of backup suppliers and the focus on a single supplier for all imported products could pose challenges in the event of supply chain disruptions. Additionally, the limited diversity in imported formulations may restrict the company's ability to adapt to changing market demands or regulatory requirements. Ensuring that VIOTONIC MEDICATION complies with international Good Manufacturing Practice (GMP) standards is essential to maintain product quality and regulatory compliance.

Strategic Implications

Importing Pharmaceuticals into Thailand — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Thailand

1Regulatory Authority & Framework

In Thailand, the Food and Drug Administration (FDA) under the Ministry of Public Health is the primary regulatory authority overseeing the importation and distribution of pharmaceutical products. The Thai FDA is responsible for ensuring the safety, efficacy, and quality of drugs entering the Thai market. Key legislation governing pharmaceutical imports includes the Drugs Act B.E. 2510 (1967) and its amendments, which outline the procedures and requirements for drug registration, importation, and distribution. The marketing authorization pathway for Indian generics involves obtaining approval from the Thai FDA, which includes submitting a comprehensive dossier, undergoing GMP inspections, and complying with labeling and packaging requirements. (en.fda.moph.go.th)

2Import Licensing & GMP

Import licensing in Thailand requires importers to obtain a license from the Thai FDA. This process involves submitting an application that includes details about the importing company, the products to be imported, and compliance with Good Manufacturing Practice (GMP) standards. The Thai FDA recognizes GMP certificates from various international standards, including EU GMP, WHO GMP, and PIC/S. Importers must ensure that their suppliers hold valid GMP certifications to facilitate the importation process. Additionally, importers must obtain a License per Invoice (LPI) for each import, which is a requirement for customs clearance. (en.fda.moph.go.th)

BZ Compnat Limited — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

BZ Compnat Limited's focus on importing products in the Advanced Oncology and Diabetes & Endocrine therapeutic categories aligns with the growing demand for treatments in these areas within Thailand. The selection of Regorafenib and Liraglutide as top imported products indicates a strategic emphasis on addressing critical health concerns prevalent in the Thai population. This targeted approach suggests that BZ Compnat Limited is positioning itself to meet specific market needs, potentially enhancing its competitive edge in these therapeutic segments.

2Sourcing Profile

BZ Compnat Limited's sourcing strategy is centered on importing generic drugs, as evidenced by the focus on Regorafenib and Liraglutide, both of which are available as generics. The company's preference for finished pharmaceutical formulations indicates a streamlined approach to procurement, likely aiming to reduce lead times and simplify the importation process. India's established pharmaceutical manufacturing capabilities and adherence to international GMP standards make it a suitable source for these products, aligning with BZ Compnat Limited's sourcing profile.

3Market Positioning

Seller's Guide — How to Become a Supplier to BZ Compnat Limited

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with BZ Compnat Limited, particularly by offering alternative products or formulations that meet the company's quality standards and regulatory requirements. Expanding the supplier base could enhance BZ Compnat Limited's supply chain resilience and provide access to a broader range of products for the Thai market. Identifying gaps in the current sourcing strategy, such as unmet therapeutic needs or emerging market trends, could present avenues for collaboration and growth.

2Requirements & Qualifications

Indian exporters seeking to supply BZ Compnat Limited must ensure that their products comply with Thai FDA regulations, including obtaining GMP certifications recognized by the Thai FDA. Products must undergo batch testing and stability studies to meet Thai standards. Labeling must be in the Thai language, providing comprehensive product information. Additionally, importers must obtain a License per Invoice (LPI) for each shipment, and the products must be registered with the Thai FDA prior to importation. (en.fda.moph.go.th)

3How to Approach

Frequently Asked Questions — BZ Compnat Limited

What products does BZ Compnat Limited import from India?

BZ Compnat Limited imports 2 pharmaceutical products across 2 categories. Top imports: Regorafenib ($5.8K), Liraglutide ($4.9K).

Who supplies pharmaceuticals to BZ Compnat Limited from India?

BZ Compnat Limited sources from 1 verified Indian suppliers. The primary supplier is Viotonic Medication (100.0% of imports, $78.0K).

What is BZ Compnat Limited's total pharmaceutical import value?

BZ Compnat Limited's total pharmaceutical import value from India is $10.7K, based on 11 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does BZ Compnat Limited focus on?

BZ Compnat Limited imports across 2 categories. The largest: Advanced Oncology (54.3%), Diabetes & Endocrine (45.7%).

Get Full BZ Compnat Limited Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.